This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Jan 30;90(5):205-206.

doi: 10.1212/WNL.0000000000004898. Epub 2018 Jan 3.

Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough

David G Munoz¹, Shinsuke Fujioka²

Affiliations

Affiliations

¹ From the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto, Canada; and Department of Neurology (S.F.), Fukuoka University, Japan. munozd@smh.ca.
² From the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto, Canada; and Department of Neurology (S.F.), Fukuoka University, Japan.

PMID: 29298853
DOI: 10.1212/WNL.0000000000004898

Editorial

Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough

David G Munoz et al. Neurology. 2018.

. 2018 Jan 30;90(5):205-206.

doi: 10.1212/WNL.0000000000004898. Epub 2018 Jan 3.

Authors

David G Munoz¹, Shinsuke Fujioka²

Affiliations

¹ From the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto, Canada; and Department of Neurology (S.F.), Fukuoka University, Japan. munozd@smh.ca.
² From the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto, Canada; and Department of Neurology (S.F.), Fukuoka University, Japan.

PMID: 29298853
DOI: 10.1212/WNL.0000000000004898

No abstract available

PubMed Disclaimer

Comment on

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Koinuma T, Ueno SI, Imamichi Y, Ueno T, Miura Y, Funayama M, Hattori N. Fujimaki M, et al. Neurology. 2018 Jan 30;90(5):e404-e411. doi: 10.1212/WNL.0000000000004888. Epub 2018 Jan 3. Neurology. 2018. PMID: 29298852 Free PMC article.

Similar articles

Relationship between caffeine intake and Parkinson disease.
Honig LS. Honig LS. JAMA. 2000 Sep 20;284(11):1378-9. JAMA. 2000. PMID: 10989385 No abstract available.
Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.
Deleu D, Jacob P, Chand P, Sarre S, Colwell A. Deleu D, et al. Neurology. 2006 Sep 12;67(5):897-9. doi: 10.1212/01.wnl.0000233916.57415.9d. Neurology. 2006. PMID: 16966563 Clinical Trial.
Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.
Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Simon DK, et al. Clin Neuropharmacol. 2015 Sep-Oct;38(5):163-9. doi: 10.1097/WNF.0000000000000102. Clin Neuropharmacol. 2015. PMID: 26366971 Free PMC article. Clinical Trial.
[Connection between caffeine, adenosine receptors and dopamine. Coffee reduces the risk of Parkinson disease].
Fredholm BB. Fredholm BB. Lakartidningen. 2004 Aug 19;101(34):2552-5. Lakartidningen. 2004. PMID: 15446691 Review. Swedish. No abstract available.
Caffeine; the Forgotten Potential for Parkinson's Disease.
Negida A, Elfil M, Attia, Farahat E, Gabr M, Essam A, Attia D, Ahmed H. Negida A, et al. CNS Neurol Disord Drug Targets. 2017;16(6):652-657. doi: 10.2174/1871527315666161107091149. CNS Neurol Disord Drug Targets. 2017. PMID: 27823571 Review.

See all similar articles

Cited by

Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target.
Behl T, Madaan P, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Chigurupati S, Alrashdi I, Bungau SG. Behl T, et al. Int J Mol Sci. 2021 Sep 21;22(18):10161. doi: 10.3390/ijms221810161. Int J Mol Sci. 2021. PMID: 34576325 Free PMC article. Review.
Addressing the Neuroprotective Actions of Coffee in Parkinson's Disease: An Emerging Nutrigenomic Analysis.
Lee LK, Mhd Rodzi NAR. Lee LK, et al. Antioxidants (Basel). 2022 Aug 16;11(8):1587. doi: 10.3390/antiox11081587. Antioxidants (Basel). 2022. PMID: 36009304 Free PMC article. Review.
Characterization of Arabica and Robusta Coffees by Ion Mobility Sum Spectrum.
Piotr Konieczka P, Aliaño-González MJ, Ferreiro-González M, Barbero GF, Palma M. Piotr Konieczka P, et al. Sensors (Basel). 2020 May 31;20(11):3123. doi: 10.3390/s20113123. Sensors (Basel). 2020. PMID: 32486481 Free PMC article.
Characterization of electrocorticographic, electromyographic and electrocardiographic recordings after the use of caffeine in Wistar rats.
Cabral DAC, Campos FMS, Silva MCPD, Medeiros JPDV, Batista PDS, Jardim GC, Machado JLP, Cabral LGC, Mello VJ, Hamoy M. Cabral DAC, et al. Einstein (Sao Paulo). 2021 Nov 15;19:eAO6417. doi: 10.31744/einstein_journal/2021AO6417. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 34787292 Free PMC article.
The Potential of Spent Coffee Grounds in Functional Food Development.
Bevilacqua E, Cruzat V, Singh I, Rose'Meyer RB, Panchal SK, Brown L. Bevilacqua E, et al. Nutrients. 2023 Feb 16;15(4):994. doi: 10.3390/nu15040994. Nutrients. 2023. PMID: 36839353 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information